These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4158914)

  • 1. Schizophrenia-melanosis: cause or side-effect?
    Greiner AC; Nicolson GA
    Lancet; 1965 Dec; 2(7423):1165-7. PubMed ID: 4158914
    [No Abstract]   [Full Text] [Related]  

  • 2. Schizophrenia melanosis. Iatrogenic--congenital defect?
    Grener AC
    Dis Nerv Syst; 1968 Mar; 29(3):Suppl:14-5. PubMed ID: 5676976
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of penicillamine on schizophrenic patients.
    Nicolson GA; Greiner AC; McFarlane WJ; Baker RA
    Lancet; 1966 Feb; 1(7433):344-7. PubMed ID: 4159479
    [No Abstract]   [Full Text] [Related]  

  • 4. Phenothiazines and diffuse melanosis.
    Greiner AC
    Agressologie; 1968; 9(2):219-24. PubMed ID: 5675489
    [No Abstract]   [Full Text] [Related]  

  • 5. Ocular effects of phenothiazine derivatives and reversibility.
    Mathalone MB
    Dis Nerv Syst; 1968 Mar; 29(3):Suppl:29-35. PubMed ID: 5672561
    [No Abstract]   [Full Text] [Related]  

  • 6. Diabetes in chronic schizophrenia.
    Marinow A
    Dis Nerv Syst; 1971 Nov; 32(11):777-8. PubMed ID: 5131772
    [No Abstract]   [Full Text] [Related]  

  • 7. Prolonged treatment of psychotic states. (Over 1600 patients treated continuously 3 to 7 years).
    Goldman D
    Dis Nerv Syst; 1968 Mar; 29(3):Suppl:51-7. PubMed ID: 4970486
    [No Abstract]   [Full Text] [Related]  

  • 8. Pigmentation due to phenothiazines in high and prolonged dosage.
    Satanove A
    JAMA; 1965 Jan; 191(4):263-8. PubMed ID: 5899740
    [No Abstract]   [Full Text] [Related]  

  • 9. Prognosis of eye complications caused by phenothiazines.
    Forrest FM; Snow HL
    Dis Nerv Syst; 1968 Mar; 29(3):Suppl:26-8. PubMed ID: 5672560
    [No Abstract]   [Full Text] [Related]  

  • 10. Abnormal movements and prognosis in schizophrenia.
    Yarden PE; Discipio WJ
    Am J Psychiatry; 1971 Sep; 128(3):317-23. PubMed ID: 5570997
    [No Abstract]   [Full Text] [Related]  

  • 11. [Affective disorders in the course of treatment with neuroleptics of children and adolescents with schizophrenia].
    Semanovskaia EI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1967; 67(10):1529-34. PubMed ID: 4386295
    [No Abstract]   [Full Text] [Related]  

  • 12. [Observations on the body experience and motor behavior of schizophrenics during neuroleptic therapy].
    Vella G; Ciani N
    Osp Psichiatr; 1965; 33(4):481-90. PubMed ID: 4381125
    [No Abstract]   [Full Text] [Related]  

  • 13. Schizophrenia and the pineal gland.
    Greiner AC
    Can Psychiatr Assoc J; 1970 Oct; 15(5):433-47. PubMed ID: 5492186
    [No Abstract]   [Full Text] [Related]  

  • 14. Melanin hyperpigmentation in South African Bantu patients with toxic psychosis.
    Robins AH
    S Afr Med J; 1972 Oct; 46(43):1639-43. PubMed ID: 4629855
    [No Abstract]   [Full Text] [Related]  

  • 15. Some effects of mesoridazine (TPS-23) on chronic psychiatric patients.
    Douglas KW; Hindley JP; Kerin MT
    Dis Nerv Syst; 1967 Feb; 28(2):113-7. PubMed ID: 6021590
    [No Abstract]   [Full Text] [Related]  

  • 16. "Miscellaneous" side effects during prolonged phenothiazine therapy.
    Zabors TE
    Wis Med J; 1967 Feb; 66(2):115-7. PubMed ID: 5342511
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of butaperazine in chronic schizophrenia.
    Clark ML; Ray TS; Huber WK; Willis D; Ramsey HR
    Clin Pharmacol Ther; 1968; 9(6):757-64. PubMed ID: 4387043
    [No Abstract]   [Full Text] [Related]  

  • 18. THERAPY OF CHLORPROMAZINE MELANOSIS: A PRELIMINARY REPORT.
    GREINER AC; NICOLSON GA; BAKER RA
    Can Med Assoc J; 1964 Sep; 91(12):636-8. PubMed ID: 14201250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative study of 2 drugs and a placebo in chronic schizophrenia].
    Tetreault L
    Actual Pharmacol (Paris); 1969; 22():1-18. PubMed ID: 4927120
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapeutic results and complications in the use of lyogen in long-term schizophrenics].
    Kutsenok BM; Zolotnitskiĭ RI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(10):1578-83. PubMed ID: 5490156
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.